In contrast, benign tumors such as fibroadenomas demonstrated only moderate FAP+ fibroblast populations, suggesting that the high FAP expression in the former tumors reflects a phenotype that may be a valuable target for therapeutic intervention. This evidence concerns the gene FAP and benign neoplasm.